CorMatrix ECM for Carotid Repair
DeviceSubjects must be undergoing carotid endarterectomy with patch angioplasty closure
NCT Number: NCT01569594
Assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair.
Looking for future studies?
Notify MeAll sexes
Observational
Cardio-Thoracic Surgeons, P.C. Trinity, Birmingham, Alabama, United States
The objective of this registry is to capture and assess device performance data from subjects undergoing patch angioplasty of the carotid artery following carotid endarterectomy using the CorMatrix ECM for Carotid Repair per its FDA cleared Indications for Use. This registry provides an ongoing post-market surveillance mechanism to document clinical outcomes on the use of the CorMatrix ECM for Carotid Repair.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects must be undergoing carotid endarterectomy with patch angioplasty closure
Time frame: 2 years
Elutia Inc.
Industry
CorMatrix® ECM® for Carotid Repair Following Endarterectomy Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05416853
Arterial Occlusive Diseases, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT05845710
Arterial Occlusive Diseases, Brain Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT03202823
Arterial Occlusive Diseases, Brain Diseases
Dijon, France
View Trial DetailsNCT03982420
Arterial Occlusive Diseases, Brain Diseases
New Haven, Connecticut, United States
View Trial Details